secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001638833-26-000044
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q1 revenue $810.9M (+4.5%), net loss $35.9M; reaffirms FY guidance
--------------------------------------------------------------------------------

- Revenue $810.9M (+4.5% YoY); same-facility revenue +4.4% on 0.6% case growth and 3.8% revenue per case.
- Net loss attributable to Surgery Partners $35.9M; Adjusted EBITDA $102.3M vs $103.9M YoY.
- Full-year 2026 guidance reaffirmed: revenue $3.35-3.45B, Adj. EBITDA at least $530M.
- Cash and equivalents $182.3M; revolver capacity $666.1M; net debt/EBITDA ratio 4.3x.
- Operating cash flow $11.7M in Q1 vs $6.0M YoY on working capital timing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/0001638833-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/sgry-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001638833-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer